Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Matthew Greenhawt to United States Food and Drug Administration

This is a "connection" page, showing publications Matthew Greenhawt has written about United States Food and Drug Administration.

 
Connection Strength
 
 
 
0.629
 
  1. Greenhawt MJ, Baldwin JL. Carmine dye and cochineal extract: hidden allergens no more. Ann Allergy Asthma Immunol. 2009 Jul; 103(1):73-5.
    View in: PubMed
    Score: 0.316
  2. Greenhawt M, Shaker M. Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care. Ann Allergy Asthma Immunol. 2020 08; 125(2):124-125.
    View in: PubMed
    Score: 0.168
  3. Shaker M, Toy D, Lindholm C, Low J, Reigh E, Greenhawt M. Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2143-2145.e4.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)